Indraprastha Medical Corporation Analysis

dividend

Pros

Cons

• Unable to calculate sustainability of dividends as Indraprastha Medical has not reported any payouts.
• Unable to evaluate Indraprastha Medical's dividend yield against the bottom 25% of dividend payers as the company has not reported any payouts.
• Unable to evaluate Indraprastha Medical's dividend against the top 25% market benchmark as the company has not reported any payouts.

health

Pros

• Indraprastha Medical is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
• Indraprastha Medical is profitable, therefore cash runway is not a concern.
• Indraprastha Medical is profitable, therefore cash runway is not a concern.
• Debt is well covered by operating cash flow (2174.9%, greater than 20% of total debt).
• Debt is covered by short term assets, assets are 35.6x debt.
• Indraprastha Medical's cash and other short term assets cover its long term commitments.
• The level of debt compared to net worth has been reduced over the past 5 years (25.7% vs 1.5% today).
• Interest payments on debt are well covered by earnings (EBIT is 9x coverage).
• Indraprastha Medical's level of debt (1.5%) compared to net worth is satisfactory (less than 40%).

Cons

• High level of physical assets or inventory.

management

Pros

• The tenure for the Indraprastha Medical board of directors is about average.
• P.'s remuneration is lower than average for companies of similar size in India.
• P.'s compensation has been consistent with company performance over the past year, both up more than 20%.
• The tenure for the Indraprastha Medical management team is about average.

Cons

misc

Pros

Cons

• Indraprastha Medical is not covered by any analysts.
• Indraprastha Medical has significant price volatility in the past 3 months.

past

Pros

• Indraprastha Medical's 1-year earnings growth exceeds its 5-year average (53.4% vs 4.5%)
• Indraprastha Medical's year on year earnings growth rate has been positive over the past 5 years.
• Indraprastha Medical used its assets more efficiently than the IN Healthcare industry average last year based on Return on Assets.
• Indraprastha Medical's earnings growth has exceeded the IN Healthcare industry average in the past year (53.4% vs 14.4%).

Cons

• Indraprastha Medical's use of capital deteriorated last year versus 3 years ago (Return on Capital Employed).
• Indraprastha Medical has not efficiently used shareholders’ funds last year (Return on Equity less than 20%).

value

Pros

• Indraprastha Medical's share price is below the future cash flow value, and at a moderate discount (> 20%).
• Indraprastha Medical's share price is below the future cash flow value, and at a substantial discount (> 40%).
• Indraprastha Medical is good value based on assets compared to the IN Healthcare industry average.
• Indraprastha Medical is good value based on earnings compared to the IN Healthcare industry average.
• Indraprastha Medical is good value based on earnings compared to the India market.
• INDRAMEDCO outperformed the Market in India which returned -14.5% over the past year.

Cons

• INDRAMEDCO underperformed the Healthcare industry which returned 9.1% over the past year.
• NSEI:INDRAMEDCO is up 4.3% underperforming the Healthcare industry which returned 5.4% over the past month.
• NSEI:INDRAMEDCO is up 4.3% underperforming the market in India which returned 8% over the past month.